Court Decision Likely To Affect Women’s Views Regarding Lipitor’s Safety
The FDA became aware of a potential diabetes problem with Lipitor, and on February 28, 2012 required labeling changes that include important new safety information—including the increased risk of developing type 2 diabetes in women taking the drug.
Prominent lawyer notes progress in liability proceedings as his law firm D. Miller & Associates, PLLC and others await final outcome.
Houston, Texas — Darren A. Miller of the Houston law firm D. Miller & Associates, PLLC says many users of the prescription drug Lipitor are focused on liability lawsuits against the drug’s maker, Pfizer, now making their way through the federal court system.
The judicial outcome could have a lasting effect on female users’ perception of Lipitor’s safety, according to Miller.
The U.S. Food and Drug Administration became aware of a potential diabetes problem with Lipitor, and on February 28, 2012 required labeling changes that include important new safety information—including the increased risk of developing type 2 diabetes in women taking the drug.
“The FDA’s warning was helpful, but it might have been too little too late for many female consumers,” Miller says. “Diabetes is a lifelong disease that often results in further complications and requires lifestyle changes including strict diet restrictions, daily blood testing and prescription medications.
”He notes that those potentially subject to compensation are post-menopausal women who have developed type 2 diabetes after taking Lipitor. “D. Miller & Associates, PLLC is ready to assist those allegedly harmed by this drug to get the relief they rightly deserve,” he says.
According to Miller the Lipitor multidistrict litigation (In Re: Lipitor Products Liability Litigation MDL No. 2459) is moving forward and will promote greater efficiency in getting related Lipitor court cases adjudicated. He adds that Lipitor is one of the top sellers in the cholesterol drug market, bringing in almost $4 billion in revenues last year according to Pfizer’s annual report.
“D. Miller & Associates, PLLC is ready to assist those allegedly harmed by this drug to get the relief they rightly deserve,” he says.According to Miller the Lipitor multidistrict litigation (In Re: Lipitor Products Liability Litigation MDL No. 2459) is moving forward and will promote greater efficiency in getting related Lipitor court cases adjudicated.He notes that Lipitor is one of the top sellers in the cholesterol drug market, bringing in almost $4 billion in revenues last year according to Pfizer’s annual report.
About D. Miller & Associates, PLLC
Founded in 2002 by attorney Darren Miller, D. Miller & Associates, PLLC is a national law firm with practice areas in personal injury, asbestos and mesothelioma, defective drugs and devices, business and criminal law. Based in Houston, Texas, the attorneys at D. Miller & Associates, PLLC, have successfully earned their clients compensation through aggressive litigation against even the most powerful of defendants.For a free legal consultation contact the firm at 1-855-776-5299
WebWireID177392
Lipitor- Contact Information
- Andrea Pisha
- Phamaceutical Legal Asst.
- D Miller & Associates, PLLC
- (1) 1-855-776-5299
- contact@dmillerlaw.com
This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.